Welcome to our dedicated page for FLAC news (Ticker: FLAC), a resource for investors and traders seeking the latest updates and insights on FLAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FLAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FLAC's position in the market.
Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) announced shareholder approval for its business combination with NewAmsterdam Pharma Holding B.V., a late clinical-stage biopharmaceutical company. Over 90% of votes favored the combination, with the transaction expected to close on November 22, 2022. About 32% of FLAC's Class A shares were redeemed for cash. The combined company will trade under the ticker symbols "NAMS" and "NAMSW" starting November 23, 2022.
NewAmsterdam Pharma and Frazier Lifesciences Acquisition Corporation (FLAC) have announced a definitive business combination agreement. The PIPE financing, totaling approximately $235 million, was oversubscribed, raising NewAmsterdam's pro forma cash balance to at least $470 million. This capital aims to support the development of obicetrapib, a novel CETP inhibitor, through multiple clinical trials until 2026. The merger is expected to close in H2 2022, pending shareholder approval. After the transaction, NewAmsterdam's ordinary shares will be listed on Nasdaq as 'NAMS'.
FAQ
What is the market cap of FLAC (FLAC)?
